KANGPU BIOPHARMACEUTICALS LTD has a total of 56 patent applications. It decreased the IP activity by 56.0%. Its first patent ever was published in 2015. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and basic materials chemistry are JIANGSU JIBEIER PHARMACEUTICAL CO LTD, CUREGENIX INC and RAPT THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 7 | |
#3 | Australia | 6 | |
#4 | Canada | 6 | |
#5 | Republic of Korea | 6 | |
#6 | Russian Federation | 6 | |
#7 | China | 4 | |
#8 | WIPO (World Intellectual Property Organization) | 4 | |
#9 | South Africa | 4 | |
#10 | Brazil | 2 | |
#11 | Hong Kong | 2 | |
#12 | New Zealand | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Basic materials chemistry | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Organic chemistry methods | |
#4 | Heterocyclic compounds | |
#5 | Pigments | |
#6 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Liao Baisong | 51 |
#2 | Lee Wen-Cherng | 45 |
#3 | Ge Chuansheng | 33 |
#4 | Zhang Lei | 16 |
#5 | Lee Wen Cherng | 6 |
#6 | Baisong Liao | 5 |
#7 | Wen-Cherng Lee | 5 |
#8 | Chuansheng Ge | 4 |
#9 | Lei Zhang | 1 |
Publication | Filing date | Title |
---|---|---|
CN110291065A | A kind of new isoindoline derivative, its pharmaceutical composition and application | |
US2019328722A1 | Combination, application thereof and treatment method | |
CA3053805A1 | Combination treating prostate cancer, pharmaceutical composition and treatment method | |
KR20180100211A | Quinazolinone derivatives, their preparation, pharmaceutical compositions and applications | |
CA3000547A1 | Pharmaceutical composition comprising benzoheterocyclic compound and androgen receptor pathway modulator for prevention or treatment of prostate cancer | |
CA2966038A1 | Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof |